Direxion Daily S&P Biotech Bear 3X Shares (LABD)

BATS BZX Real-Time Price
As of 3:50pm ET
 +5.53 / +16.34%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the daily performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.

5 Best Inverse/Leveraged ETF Areas of Last Week
Jan 10 / Zacks.com - Paid Partner Content


1 month+14.91% 3 years-61.19%
3 months+64.89% 5 years-58.36%
1 year+76.51% Since inception-56.01%
Data through 01/15/2022

Quote Details

Previous close$33.85
Open day’s range35.46 – 39.60
Net asset value (NAV)33.76 (01/14/2022)
Daily volume3,602,404
Average volume (3 months)2,568,453
Data as of 3:50pm ET, 01/18/2022

Peer Comparisonvs. Trading--inverse equity ETFs

Performance 5-yr return-58.36%-29.79%
Expense Gross exp ratio1.11%--
Risk 5 year sharpe ratio-0.98--
Net assets$40.4M--
Average market cap--$141.0B
Average P/E--21.3
Dividend / Share--9.82%


SPDN Direxion Daily S&P 500® Bear 1X Shares
TAIL Cambria Tail Risk ETF
SH ProShares Short S&P500


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
FTIXX Goldman Sachs Financial Square Treasury Instruments Fund Institutional Shares72.26%
DAPXX Dreyfus Government Securities Cash Management Administrative Shares48.44%
-- 2.85%
-- 0.00%